The distribution agreement covers Elekta’s Leksell Vantage Steretactic target localization and coordinate referencing neurosurgery system, the company said, which received CE Mark approval in the EU in March. The device is currently pending 510(k) clearance in the US, Elekta added. The agreement also covers the Leksell Stereotactic system and Elekta Microdrive.
“Elekta is a leader of equipment for stereotactic neurosurgery and Brainlab has a strong presence in the neurosurgery market with its software solutions. This collaboration helps to strengthen and streamline the service and support to our customers starting in France, Belgium, Poland, Liechtenstein, Luxemburg, Portugal and Spain. With this, they will be able to access a complete solution from a single source,” Elekta western & central Europe senior VP François Pointurier said in prepared remarks.
Stockholm-based Elekta said it began collaborating with Brainlab last year to improve the interopability and safety of stereotactic surgery through the integration of Elekta’s Leksell Vantage stereotactic system into Brainlab’s Elements Stereotaxy software.
“A distribution partnership between Brainlab and Elekta will provide clinicians with improved and standardized stereotactic neurosurgery workflows,” Brainlab prez & CEO Stefan Vilsmeier said in a prepared statement.
“This latest collaboration between our companies will be mutually beneficial, strengthening our respective combined offer in neurosurgery. By joining forces in sales and support, we aim to strengthen our relationship with the neurosurgery community by offering more solutions from the Elekta portfolio,” Elekta chief strategy officer Maurits Wolleswinkel said in a press release.